Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | PPARG | P37231 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | NOS1 | P29475 | 2/20 | 0.35 |
| ▸ | NOS2 | P35228 | 2/20 | 0.35 |
| ▸ | PDE9A | O76083 | 2/20 | 0.33 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13477018 | 1.00 | CYP1A2 (0.58) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL1930905 | 0.94 | CYP1A2 (0.56) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL2818882 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL15658728 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL15658234 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL24667636 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL24668103 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL1301295 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL5998582 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 | |
| SCHEMBL11099421 | 0.92 | CYP1A2 (0.54) | CYP1A2PPARGCA1CA9CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1074 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | FIRMENICH & CIE (CH) | 2026-03-12 | — | — | US | claimed |
| US-12568998-B2 | Flavouring composition with balanced taste profile | SYMRISE AG (DE) | 2026-03-10 | — | — | US | claimed |
| US-12559703-B2 | Fragrance composition | GIVAUDAN SA (CH) | 2026-02-24 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4655373-A1 | BIODEGRADABLE PERFUME COMPOSITION | Givaudan SA (CH) | 2025-12-03 | — | — | EP | claimed |
| US-20250352444-A1 | Antimicrobial mixtures | SYMRISE AG (DE) | 2025-11-20 | — | — | US | claimed |
| US-20250302678-A1 | ABSORBENT ARTICLES INCLUDING PERFUME AND CYCLODEXTRINS | PROCTER & GAMBLE (US) | 2025-10-02 | — | — | US | claimed |
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| US-20250295123-A1 | Arthropod Control Compositions | FIRMENICH & CIE (CH) | 2025-09-25 | — | — | US | claimed |
| EP-1214972-B1 | Method for preparing lactone | DAIREN CHEMICAL CORP (TW) | 2003-06-04 | — | — | EP | claimed |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | SODA AROMATIC CO., LTD. A JAPANESE CORPORATION (JP) | 2003-03-20 | — | — | US | claimed |
| CN-1394139-A | Anticancer agents | SODA AROMATIC (JP) | 2003-01-29 | — | — | CN | claimed |
| EP-1249236-A1 | ANTICANCER AGENTS, PERFUMES OR FOODS AND DRINKS CONTAINING $g(v)-HYDROXYFATTY ACIDS | SODA AROMATIC COMPANY, LIMITED (JP) | 2002-10-16 | — | — | EP | claimed |
| US-20020120154-A1 | Method for preparing lactam | DAIREN CHEMICAL CORPORATION (TW) | 2002-08-29 | — | — | US | claimed |
| EP-1214972-A1 | Method for preparing lactone | Dairen Chemical Corporation (TW) | 2002-06-19 | — | — | EP | claimed |
| EP-1201652-A1 | Process for the preparation of lactams | Dairen Chemical Corporation (TW) | 2002-05-02 | — | — | EP | claimed |
| US-6350883-B1 | REACTION OF LACTONE WITH AMINE OR AMMONIA TO FORM A LACTAM | DAIREN CHEMICAL CORPORATION (TW) | 2002-02-26 | — | — | US | claimed |
| US-6323347-B2 | USED FOR DEHYDROCYCLIZATION REACTION OF A DIOL UNDER A GAS PHASE TO FORM LACTONE; ACTIVITY, LONG LIFETIME AND HIGH SELECTIVITY OF PRODUCTS | DAIREN CHEMICAL CORPORATION (TW) | 2001-11-27 | — | — | US | claimed |
| US-20010009964-A1 | Catalyst for preparing lactone and a method for preparing lactone | DAIREN CHEMICAL CORPORATION (TW) | 2001-07-26 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12568998-B2 | Flavouring composition with balanced taste profile | TAS2R20, TAS2R50, TAS2R40 | CYP1A2 2295/4885PPARG 3825/4885CA1 2043/4885 |
| US-20260068882-A1 | ARTHROPOD CONTROLLING COMPOSITION | CNOT9, MSL1, MT-CO2 | CYP1A2 841/4885PPARG 4028/4885CA1 1607/4885 |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | CYP1A2 274/4885PPARG 1255/4885CA1 151/4885 |
| US-20020120154-A1 | Method for preparing lactam | AGL, APH1A, DCXR | CYP1A2 582/4885PPARG 3282/4885CA1 1867/4885 |
| US-20030055105-A1 | Anticancer agents, perfumes or foods and drinks containing omega-hydroxyfatty acids | ALOX5, ELOVL5, ELOVL3 | CYP1A2 640/4885PPARG 192/4885CA1 1636/4885 |
| US-12559703-B2 | Fragrance composition | DHCR24, OPRD1, OR10J3 | CYP1A2 234/4885PPARG 2671/4885CA1 1931/4885 |
| US-20250352444-A1 | Antimicrobial mixtures | LRBA, MGLL, TAS2R50 | CYP1A2 3031/4885PPARG 273/4885CA1 4319/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | CYP1A2 1105/4885PPARG 2174/4885CA1 1069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.